bankingdive6d
Fed releases 2025 stress test scenarios
The stress test, which will include 22 banks compared to last year’s 32, will feature two added hypothetical elements for the ...
gh.bmj2h
Extending a parallel cluster randomised trial into a stepped-wedge cluster randomised trial: implications for interpretation
The PACK trial 1 was a parallel-arm cluster randomised trial, assigning 48 clinics to the intervention arm (a training ...
Scientific Research Publishing13h
Exploring Cyber Threat Intelligence into Land Administration Systems for Enhanced Cyber Resilience ()
Cyber Threat Intelligence, Common Vulnerabilities and Exposures, Geodata, Land Administration Systems, Risk Assessment, Spatial Cadastral Data Share and Cite: Blin, P. , Aditya, T. , Santosa, P. and ...
Recursion Presents Phase 2 Data for REC-994 in CCM in Late-Breaking Oral Presentation at the International Stroke Conference
Met primary endpoint of safety and tolerability in CCM patients with no treatment-related discontinuations or Grade 3 adverse ...
Le Lézard1d
Lineage Initiates Clinical Study of OPC1 for Spinal Cord Injury
Lineage Cell Therapeutics, Inc. , a clinical-stage biotechnology company developing allogeneic cell therapies for serious neurological conditions, announced today that the Company has initiated the ...
thorax.bmj3d
Inflammation in preschool cystic fibrosis is of mixed phenotype, extends beyond the lung and is differentially modified by CFTR modulators
Background Early-life inflammation has long been recognised as a key pathophysiological process in the evolution of cystic ...
Esperion stock holds Buy rating, $16 target from H.C. Wainwright
H.C. Wainwright maintained a positive stance on Esperion Therapeutics (NASDAQ:ESPR) shares, reaffirming a Buy rating and a price target of $16.00. According to InvestingPro data, analyst targets for ...
Viking Therapeutics, Inc.: Viking Therapeutics Reports Fourth Quarter and Year-End 2024 Financial Results and Provides Corporate Update
Conference call scheduled for 4:30 p.m. ET today Initiation of Phase 3 Studies for Subcutaneous VK2735 for Obesity Planned for 2Q25 Phase 2 VENTURE-Oral Dosing Trial ...
AEC Magazine3d
Motif to take on Revit: exclusive interview
In this exclusive interview with CEO Amar Hanspal, we get the low down on the $46m funded BIM startup Motif, whose aim is to ...
NIH cuts put medical research at risk, scientists say, raising concerns at UC and elsewhere
Drastic cuts to National Institutes of Health 'indirect funds' for medical research has prompted deep concerns at UC over how ...
Pew Research Center6h
1. Americans’ views on COVID-19 risk and the country’s response to health emergencies
Eileen Yam and Giancarlo Pasquini contributed to this chapter. Five years after the pandemic began, Americans largely see ...
Tackling Complexities with Simplicity: PPI’s Ray Sheen on Threats, Opportunities, & the Uniqueness of Project Management
Boasting over 30 years of industry experience, Ray Sheen, President at Product & Process Innovation, Inc., (PPI), has felt ...